GoodRx Holdings, Inc. (NASDAQ: GDRX) reported Q3 EPS of $0.08, $0.01 worse than the analyst estimate of $0.09. Revenue for the quarter came in at $196 million versus the consensus estimate of $194.55 million.

For earnings history and earnings-related data on GoodRx Holdings, Inc. (GDRX) click here.